The Josep Carreras Leukaemia Research Institute (IJC) is a comprehensive cancer research center dedicated to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases. It was created in 2010, and since then has experienced an exponential growth.

The IJC is also part of the network of Excellence Research Centers of Catalonia (CERCA) and was accredited as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation, and Universities in 2024. Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC) Additionally, IJC is one of the centers integrated into the Institut de Recerca Germans Trias i Pujol (IGTP) accreditation as Accredited Health Research Institute (IIS) by the Carlos III Health Institute (ISCIII).

The IJC's main headquarters is located within the Can Ruti Biomedical Campus, alongside other leading biomedical institutions, providing direct access to cutting-edge scientific and technological facilities, as well as complementary community services. The IJC has six locations integrated into reference hospitals: Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Josep Trueta, Hospital del Mar and Hospital San Joan de Déu. This facilitates close collaboration between basic and clinical researchers, fostering translational research that integrates basic science with clinical practice in clinical settings.

YOUR MISSION

The Communication Unit contributes to strengthening the Institute’s visibility, positioning, and social impact through strategic communication, science outreach, institutional relations, and the organization of institutional and scientific events aligned with the centre’s mission and objectives. The Unit promotes rigorous, coherent, and impactful communication to enhance scientific excellence, international visibility, and engagement with society.

The Josep Carreras Leukaemia Research Institute (IJC) is seeking an Specialist Officer in Scientific Communication to develop and implement scientific communication and outreach initiatives.

MAIN RESPONSABILITIES

• Writing scientific news articles, feature articles, and press releases, ensuring high-quality content aligned with the Institute’s strategic priorities.

• Designing and implementing science communication and outreach projects, including participation in external activities and the development of in-house initiatives, with the aim of reinforcing the Institute’s positioning as a centre of excellence.

• Reviewing the technical and scientific aspects of institutional and social media content to ensure clear, coherent communication aligned with the Institute’s mission.

• Coordinating relationships with educational institutions and research centres to foster institutional collaboration and knowledge transfer.

• Participating in the review and adaptation of institutional texts to ensure message consistency and compliance with the Institute’s corporate and visual identity.

• Supporting institutional events, ensuring their successful execution and contributing to strengthening the Institute’s internal and external image.

WHAT WE NEED

• Bachelor’s degree in the field of biosciences.

• A master’s degree in science communication will be considered an asset.

• Experience in research centres will be valued.

• Knowledge of audiovisual editing tools will be considered an asset.

• Proficient in writing and speaking in English.

• Proactivity, initiative and solving problem’s ability.

• Ability to work independently and efficiently.

• Ability to work within tight deadlines and manage multiple projects simultaneously.

• Strong organizational, planning, and analytical skills.

• Ability to work cooperatively and inclusively with others to achieve shared goals.

• Passion for our mission and to contribute to boosting the societal impact of blood cancer research.

WHAT WE OFFER

• Full-time contract (39h per week).

• Temporary replacement contract until the position is filled

• Measures to reconcile work and family life (Flexible working hours, remote working, 23 vacation days in 2026, and 11 personal days in 2026)

• Flexible remuneration program (kindergarten and other measures).

• Training and development opportunities.

• Incorporation in a multinational and highly collaborative team.

• Competitive salary commensurate with experience and qualifications.

• Managing a new strategic platform in the institute

• An innovative and interdisciplinary research project.

• Mixed basic and clinical research environment of the Josep Carreras Leukaemia Research Institute.

• Competitive salary to be further defined depending on candidate experience.

• Enjoy the vibrant surroundings of the Barcelona metropolitan area, IJC headquarters located in nature.

DEADLINE

Please submit your application by July 9, 2026.

WHO WE ARE?

What makes us different?

The mission of the Josep Carreras Leukaemia Research Institute is to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of cancer, with a special emphasis on Leukaemia and other malignant blood diseases, with the aim of finding a cure for these diseases.
The IJC’s vision is to be a world-class reference and excellent research center that contributes to the improvement of results, and the cure of patients affected by leukaemia and other malignant haemopathies, through innovation, sustainability, social responsibility, talent, and professional experience.

HR Excellence

In 2019, IJC was honored with the “Human Resources Excellence in Research Award” by the European Commission, recognizing the alignment of our human resources policies with the European Charter for Researchers and Code of Conduct for the Recruitment of Researchers. The Human Resources Strategy for Researchers (HRS4R) guides research centers of excellence in implementing and upholding these standards within their policies, emphasizing training, professional development, and mobility opportunities.
The IJC’s commitment to these values and principles strengthens our internal policies and ensures that our members have the optimal conditions and environment for their professional development.
The Board of Trustees is composed of representatives of the Generalitat de Catalunya (regional government), University of Barcelona, Autonomous University of Barcelona, the City of Badalona and the Jose Carreras International Leukaemia Foundation
The Catalan government provides hard money on an annual basis. The Jose Carreras International Leukaemia Foundation provides start-up funds, project funds as well as financial support for investments.
The JCI has an international scientific advisory board served by prominent researchers from US and Europe.
The IJC has been awarded ERC and other EU grants.

The IJC is an equal-opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, or other legally protected characteristics.